Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 5Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Colorectal Neoplasms 2Adenocarcinoma 2Rectal Neoplasms 1Rectal Diseases 1Metastatic Adenocarcinoma of the Pancreas 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Neoplasms 1Colonic Diseases 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 1Nivolumab 1Leucovorin 1Ipilimumab 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Adenocarcinoma Of Esophagus × Oxaliplatin × Clear all
NCT02872116 2025-08-07

CheckMate649

Bristol-Myers Squibb

Phase 3 Completed
2,031 enrolled 19 charts 1 FDA
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡